(Q51742200)

English

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.

scientific article published on 14 April 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

object named as

Erica M Wood

5

0 references

Lise J Estcourt

object named as

Lise J Estcourt

2

0 references

Simon Stanworth

1

object named as

Simon J Stanworth

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

author name string

Charlotte A Llewelyn

3

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

Michael F Murphy

4

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

TOPPS Study Investigators

6

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

publication date

14 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

54

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

10

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

2385-2393

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

A no-prophylaxis platelet-transfusion strategy for hematologic cancers

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Platelet transfusions for patients with haematological malignancies: who needs them?

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic plat

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Improper analysis of trials randomised using stratified blocks or minimisation

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Guidelines for the use of platelet transfusions

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Statistics in medicine--reporting of subgroup analyses in clinical trials.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Statistics notes: Absence of evidence is not evidence of absence

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Haematological cancer: Prophylactic platelet transfusion is frequently not necessary

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Inflammation induces hemorrhage in thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Challenges in the management of the blood supply

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12646

21 January 2018

Identifiers

10.1111/TRF.12646

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24724863

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51742200&oldid=1836196029"